The investigation determined that a higher than expected vitros phyt quality control result and a higher than expected vitros crbm quality control result were obtained from a vitros therapeutic drug monitoring performance verifier processed using vitros chemistry products phyt slides lot 2621-0177-0750 and vitros chemistry products crbm slides lot 3903-0112-9906 on two different vitros 4600 chemistry systems.The assignable cause of the events is suboptimal calibrations most likely caused by turbidity of the fluids of the vitros cal kit 9 lot 0959 and 0969 in use at the time of the event.The parameters for the initial vitros phyt and crbm calibrations were atypical compared to the database values.After recalibration of both assays using an alternate lot of vitros cal kit 9 that were not turbid, acceptable post calibration qc results were obtained.Ortho currently has an investigation open, complaint investigation 496760, for turbid and discolored fluid in vitros cal kit 9 lots 0959, 0969, 0970 and 0991 as well as vitros tdm i x8115 and tdm ii y8116.As vitros phyt lot 2621-0177-0750 and vitros crbm lot 3903-0112-9906 were new reagent lots for the customer at the time of the events, no historical qc results were available for evaluation.Therefore, a reagent related issue could not be entirely ruled out as a contributor of the events.Although no precision testing was performed on the vitros 4600 systems, an instrument related issue is not a likely contributor of the events as acceptable results were obtained on both instruments without any known actions being performed on the instruments other than recalibration of the assays.Continual tracking and trending of complaints has not identified any signals that would indicate a potential systematic issue with vitros phyt reagent lot 2621-0177-0750 or vitros crbm reagent lot 3903-0112-9906.Email address for contact office is (b)(4).
|